PR Newswire - Senhwa Biosciences Launches Global Study, Targetin...
TAIPEI and SAN DIEGO, May 5, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company today announced the initiation of a global, multi-center clin...
Read More

ภาษาไทย
English